Akebia Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKBA and other ETFs, options, and stocks.About AKBA
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders.
AKBA Key Statistics
Stock Snapshot
Akebia Therapeutics(AKBA) stock is priced at $1.17, giving the company a market capitalization of 313.18M. It carries a P/E multiple of -15.03.
On 2026-05-09, Akebia Therapeutics(AKBA) stock traded between a low of $1.13 and a high of $1.20. Shares are currently priced at $1.17, which is +4.0% above the low and -2.5% below the high.
The Akebia Therapeutics(AKBA)'s current trading volume is 4.4M, compared to an average daily volume of 3.61M.
In the last year, Akebia Therapeutics(AKBA) shares hit a 52-week high of $4.08 and a 52-week low of $1.13.
In the last year, Akebia Therapeutics(AKBA) shares hit a 52-week high of $4.08 and a 52-week low of $1.13.
AKBA News
Akebia Therapeutics, Inc. has reported past first-quarter 2026 results showing revenue of US$53.54 million versus US$57.34 million a year earlier, with net loss...
Akebia Therapeutics ((AKBA)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and...
Image source: The Motley Fool. Thursday, May 7, 2026 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer — John Butler President, Nephrology — Nicholas Grun...
More AKBA News
Reports Q1 revenue $53.54M, consensus $51.57M. “The number of patients on Vafseo increased through the start of the year, and we are further encouraged by trend...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.